Ashkon Software

   







 


CLTX - Celsus Therapeutics Plc

Celsus Therapeutics Plc logo Celsus Therapeutics Plc is no longer listed on any major stock exchanges and is no longer publicly traded. The last available information about the company dates back to 2018 when it was a clinical-stage biopharmaceutical company focused on the development of treatments for dermatological conditions.

At that time, the company's lead product candidate was MRX-6, a topical treatment for psoriasis that was in Phase 2 clinical trials. The company also had several other product candidates in preclinical development for the treatment of psoriasis, eczema, and other dermatological conditions.

However, it appears that the company has faced significant challenges in its drug development efforts and financial position. In 2019, the company entered into administration proceedings in the UK, which typically involve the appointment of an independent administrator to manage the company's affairs and assets in an effort to pay off

 



 

 

 
Copyright © 2000-2023, Ashkon Software LLC
Privacy Policy | Refund Policy | Disclaimer